Home » Blood Typing, Grouping and Infectious Disease

Blood Typing, Grouping and Infectious Disease Screening Market By Test Type (ABO Grouping, Immunoassay Screening, Nucleic Acid Testing (NAT)), By Product Type (Instruments, Consumables, Kits), By Infectious Agent (Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human T-Lymphotropic Virus (HTLV), Treponema Pallidum, Trypanosoma Cruzi, West Nile Virus (WNV), Cytomegalovirus (CMV), Other Agents) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 2659 | Report Format : PDF

Industry Outlook

The global blood typing, grouping, and infectious disease screening market will reach US$ 7,078.3 million by 2026, up from US$ 3,079.8 million in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026. Blood grouping comprises ABO grouping and Rh tests, whereas nucleic acid testing (NAT) and immunoassays are preferred for blood screening to identify the presence of infectious agents. The major factors affecting market growth include increasing blood donations and growing awareness among blood donors, rising affordability of advanced diagnostic tests such as NAT for blood screening, and increasing awareness of the need for infection-free blood during donations. Furthermore, the growing cases of road accidents and trauma cases demand a huge quantity of blood, which requires blood screening kits and consumables, thereby accounting for market growth. Additionally, the growing cases of infections (particularly viral infections) raise the demand for diagnosis kits. The Centers for Disease Control and Prevention (CDC) reported approximately 2,150 cases of West Nile Virus (WNV) infections in the United States in 2016. According to HIV.gov (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary’s Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported at around 36.7 million globally, among which 2.1 million patients are less than 15 years of age. In 2016, there were approximately 1.8 million reported HIV incident cases worldwide, resulting in approximately 5,000 infections per day. Furthermore, around 60% of the United States population is expected to be infected by cytomegalovirus (CMV) once before the age of 40. The high number of infections worldwide indicates a high demand for efficient and accurate diagnostic and blood screening kits, which accounts for market growth.

Market Synopsis

Growing Demand for Blood and Blood Products to Support Dominance of the ABO Grouping Segment

In 2017, the ABO grouping segment dominated the global blood typing, grouping, and infectious disease screening market with over 45% market share in terms of value. The dominance of the segment is attributed to the growing demand for blood and blood products in the market. Furthermore, the rising cases of road accidents fuel the demand for the ABO grouping segment. According to the Insurance Institute for Highway Safety (IIHS), approximately 34,439 fatal motor vehicle crashes were reported in the United States in 2016, indicating a high demand for blood and thus contributing to segment growth. Additionally, the Nucleic Acid Testing (NAT) segment was identified to experience lucrative growth with the fastest CAGR owing to the growth of infectious diseases.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

The consumables segment dominated the global market through the forecast period.

In 2017, the consumables segment dominated the global market and was expected to witness the fastest growth during the forecast period from 2018 to 2026. Consumables are inevitably required to perform the tests in huge amounts, so the requirement of large volumes plays a key role in the dominance of the segment in the global market. The currently available assay kits are easy to use and handle and deliver high-precision results. Technological advancement in diagnostic instruments further increases the accuracy of the tests, subsequently driving the market.

High Cytomegalovirus (CMV) Infection Rate to Aid Market Position for Blood Screening Tests

According to the CDC, at least 60% of Americans are exposed to the cytomegalovirus, and one in every three women infected with CMV is expected to pass the virus on to their unborn child. Additionally, on average, 150 infants are born with CMV infections each year in the United States. Such high infection rates of CMV account for the high demand for diagnosis and contribute to the supremacy of the CMV segment. Furthermore, cases of other infections are also rising, which accounts for the lucrative growth of the market during the forecast period from 2018 to 2026.

During the forecast period, Asia Pacific is expected to grow at a double-digit CAGR, followed by Latin America.

The Asia Pacific was expected to witness lucrative growth during the forecast period owing to high awareness of blood donations, growing road accidents and injuries in the region, and growing cases of infections. Additionally, the rising accessibility of diagnostic techniques and the penetration of the major players in developing countries in Asia Pacific and Latin America contribute to the double-digit growth of both regional markets. In 2017, North America dominated the global market with over 34% of the market share in terms of value. The prime reasons for the dominance of the region are the high incidence of infectious diseases, costly treatment regimens compared to other parts of the world, and the availability of better diagnostic devices.

The presence of numerous players has fragmented the global market.

The global blood typing, grouping, and infectious disease screening market is highly fragmented and comprises numerous players. Several players in the market are involved in the manufacturing of kits and reagents used for ABO blood grouping and the diagnosis of infectious diseases. Key players in the market include Abbot Laboratories, Inc., Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Grifols S.A., Immucor, Inc., Ortho Clinical Diagnostics, Quotient Ltd., and Thermo Fisher Scientific, Inc.

Periods of History and Forecast

For the purpose of this research study, 2017 is considered the base year, and the forecast years are from 2018 to 2026.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Scope by Segments

The scrutiny of the blood typing, grouping, and infectious disease screening market is performed by segmenting the market in terms of product type, test type, infectious agent, and geography.

This analysis further explains the key qualitative market assessment parameters, including key market trends such as DROs, to assist in a better understanding of the global blood typing, grouping, and infectious disease screening markets. Additionally, the major players are graphically mapped based on their market strategies, product offerings, and business strengths.

Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global BTGIDS Market Portraiture
2.2. Global BTGIDS Market, by Test Type, 2017 (US$ Mn)
2.3. Global BTGIDS Market, by Product Type, 2017 (US$ Mn)
2.4. Global BTGIDS Market, by Infectious Agent, 2017 (US$ Mn)
2.5. Global BTGIDS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Blood Typing, Grouping and Infectious Disease Screening  (BTGIDS) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Incidence of Viral Infections
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Blood Typing, Grouping and Infectious Disease Screening  (BTGIDS) Market, by Test Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. ABO Grouping
4.3. Immunoassay Screening
4.4. Nucleic Acid Testing (NAT)

Chapter 5. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market, by Product Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Instruments
5.3. Consumables
5.4. Kits

Chapter 6. Global Blood Typing, Grouping and Infectious Disease Screening  (BTGIDS) Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Hepatitis B Virus (HBV)
6.3. Hepatitis C Virus (HCV)
6.4. Human Immunodeficiency Virus (HIV)
6.5. Human T-Lymphotropic Virus (HTLV)
6.6. Treponema pallidum (T. palladium)
6.7. Trypanosoma cruzi (T. cruzi)
6.8. West Nile Virus (WNV)
6.9. Cytomegalovirus (CMV)
6.10. Other Agents (Parvovirus, Ebola Virus, etc.)

Chapter 7. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America BTGIDS Market, 2016 – 2026 (US$ Mn)
7.2.1. North America BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
7.2.2. North America BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
7.2.3. North America BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
7.2.4. North America BTGIDS Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. United States
7.2.4.2. Canada
7.3. Europe BTGIDS Market, 2016 – 2026 (US$ Mn)
7.3.1. Europe BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
7.3.2. Europe BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
7.3.4. Europe BTGIDS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. United Kingdom
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific BTGIDS Market, 2016 – 2026 (US$ Mn)
7.4.1. Asia Pacific BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific BTGIDS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of Asia Pacific
7.5. Latin America BTGIDS Market, 2016 – 2026 (US$ Mn)
7.5.1. Latin America BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
7.5.2. Latin America BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America BTGIDS Market, by Infectious Type, 2016 – 2026 (US$ Mn)
7.5.4. Latin America BTGIDS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa BTGIDS Market, 2016 – 2026 (US$ Mn)
7.6.1. Middle East & Africa BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
7.6.2. Middle East & Africa BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
7.6.3. Middle East & Africa BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
7.6.4. Middle East & Africa BTGIDS Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Becton, Dickinson and Company
8.3. bioMérieux SA
8.4. Bio-Rad Laboratories, Inc.
8.5. DiaSorin S.p.A
8.6. F. Hoffmann-La Roche Ltd.
8.7. Grifols S.A
8.8. Immucor, Inc.
8.9. Ortho Clinical Diagnostics
8.10. Quotient Ltd.
8.11. Thermo Fisher Scientific, Inc.

List of Figures

FIG. 1 Market Segmentation: Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market
FIG. 2 Research Methodology: Global BTGIDS Market
FIG. 3 Global BTGIDS Market, by Test Type, 2017 (US$ Mn)
FIG. 4 Global BTGIDS Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global BTGIDS Market, by Infectious Agent, 2017 (US$ Mn)
FIG. 6 Global BTGIDS Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: Global BTGIDS Market, by Geography, 2017
FIG. 8 Competitive Landscape: Global Blood Typing Grouping and Infectious Disease Screening Market, by Key Players, 2017
FIG. 9 Global ABO Grouping Market for BTGIDS, 2016 – 2026 (US$ Mn)
FIG. 10 Global Immunoassay Screening Market for BTGIDS, 2016 – 2026 (US$ Mn)
FIG. 11 Global Nucleic Acid Testing (NAT) Market for BTGIDS, 2016 – 2026 (US$ Mn)
FIG. 12 Global Instruments Market for BTGIDS, 2016 – 2026 (US$ Mn)
FIG. 13 Global Consumables Market for BTGIDS, 2016 – 2026 (US$ Mn)
FIG. 14 Global Kits Market for BTGIDS, 2016 – 2026 (US$ Mn)
FIG. 15 Global BTGIDS Market for Hepatitis B Virus (HBV), 2016 – 2026 (US$ Mn)
FIG. 16 Global BTGIDS Market for Hepatitis C Virus (HCV), 2016 – 2026 (US$ Mn)
FIG. 17 Global BTGIDS Market for Human Immunodeficiency Virus (HIV), 2016 – 2026 (US$ Mn)
FIG. 18 Global BTGIDS Market for Human T-Lymphotropic Virus (HTLV), 2016 – 2026 (US$ Mn)
FIG. 19 Global BTGIDS Market for Treponema pallidum (T. palladium), 2016 – 2026 (US$ Mn)
FIG. 20 Global BTGIDS Market for Trypanosoma cruzi (T. cruzi), 2016 – 2026 (US$ Mn)
FIG. 21 Global BTGIDS Market for West Nile virus (WNV), 2016 – 2026 (US$ Mn)
FIG. 22 Global BTGIDS Market for Cytomegalovirus (CMV), 2016 – 2026 (US$ Mn)
FIG. 23 Global BTGIDS Market for Other Agents, 2016 – 2026 (US$ Mn)
FIG. 24 United States BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 25 Canada BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 26 United Kingdom BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 27 Germany BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Europe BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 29 Japan BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 30 China BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 31 Rest of Asia Pacific BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 32 Brazil BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 33 Mexico BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 34 Rest of Latin America BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 35 GCC BTGIDS Market, 2016 – 2026 (US$ Mn)
FIG. 36 Rest of Middle East & Africa BTGIDS Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market Portraiture
TABLE 2. Global BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 3. Global BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 4. Global BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
TABLE 5. Global BTGIDS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6. North America BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 7. North America BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 8. North America BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
TABLE 9. North America BTGIDS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10. Europe BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 11. Europe BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 12. Europe BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
TABLE 13. Europe BTGIDS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14. Asia Pacific BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 15. Asia Pacific BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 16. Asia Pacific BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
TABLE 17. Asia Pacific BTGIDS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18. Latin America BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 19. Latin America BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 20. Latin America BTGIDS Market, by Infectious Disease, 2016 – 2026 (US$ Mn)
TABLE 21. Latin America BTGIDS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22. Middle East & Africa BTGIDS Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 23. Middle East & Africa BTGIDS Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 24. Middle East & Africa BTGIDS Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
TABLE 25. Middle East & Africa BTGIDS Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 26. Abbot Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27. Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28. bioMérieux SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29. Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30. DiaSorin S.p.A: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31. F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32. Grifols S.A: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33. Immucor, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34. Ortho Clinical Diagnostics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35. Quotient Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36. Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions

What is the size of Blood Typing, Grouping and Infectious Disease Screening Market?

The market for Blood Typing, Grouping and Infectious Disease Screening is expected to reach US$ 3,079.8 Mn in 2026.

What is the Blood Typing, Grouping and Infectious Disease Screening Market CAGR?

The Blood Typing, Grouping and Infectious Disease Screening market is expected to see significant CAGR growth over the coming years,at 9.7%.

What is the Forecast period considered for Blood Typing, Grouping and Infectious Disease Screening Market?

The report is forecasted from 2018-2026.

What is the base year considered for Blood Typing, Grouping and Infectious Disease Screening Market?

The base year of this report is 2017.

Who are the major players in this Market?

Abbott Laboratories Inc.,Becton, Dickinson and Company,bioMérieux SA,Bio-Rad Laboratories, Inc.,DiaSorin S.p.A are some of the major players in the global market.

MRI Guided Neurosurgical Ablation Market

Published:
Report ID: 33742

Glycated Albumin Assay Market

Published:
Report ID: 33574

Proliferative Diabetic Retinopathy Market

Published:
Report ID: 33536

Endoscopic Ultrasound (EUS) Needles Market

Published:
Report ID: 4131

Healthcare POS Terminals Market

Published:
Report ID: 13903

Optogenetics Market

Published:
Report ID: 8143

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN